AUPQ272699A0 - Use of beta2GPI in diagnostic tests for autoimmune diseases - Google Patents

Use of beta2GPI in diagnostic tests for autoimmune diseases

Info

Publication number
AUPQ272699A0
AUPQ272699A0 AUPQ2726A AUPQ272699A AUPQ272699A0 AU PQ272699 A0 AUPQ272699 A0 AU PQ272699A0 AU PQ2726 A AUPQ2726 A AU PQ2726A AU PQ272699 A AUPQ272699 A AU PQ272699A AU PQ272699 A0 AUPQ272699 A0 AU PQ272699A0
Authority
AU
Australia
Prior art keywords
beta2gpi
autoimmune diseases
diagnostic tests
diagnostic
tests
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ2726A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unisearch Ltd
Original Assignee
Unisearch Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unisearch Ltd filed Critical Unisearch Ltd
Priority to AUPQ2726A priority Critical patent/AUPQ272699A0/en
Publication of AUPQ272699A0 publication Critical patent/AUPQ272699A0/en
Priority to AU73930/00A priority patent/AU7393000A/en
Priority to PCT/AU2000/001068 priority patent/WO2001018541A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AUPQ2726A 1999-09-09 1999-09-09 Use of beta2GPI in diagnostic tests for autoimmune diseases Abandoned AUPQ272699A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPQ2726A AUPQ272699A0 (en) 1999-09-09 1999-09-09 Use of beta2GPI in diagnostic tests for autoimmune diseases
AU73930/00A AU7393000A (en) 1999-09-09 2000-09-08 Use of beta2gpi in diagnostic tests for autoimmune diseases
PCT/AU2000/001068 WO2001018541A1 (en) 1999-09-09 2000-09-08 Use of beta2gpi in diagnostic tests for autoimmune diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ2726A AUPQ272699A0 (en) 1999-09-09 1999-09-09 Use of beta2GPI in diagnostic tests for autoimmune diseases

Publications (1)

Publication Number Publication Date
AUPQ272699A0 true AUPQ272699A0 (en) 1999-09-30

Family

ID=3816896

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ2726A Abandoned AUPQ272699A0 (en) 1999-09-09 1999-09-09 Use of beta2GPI in diagnostic tests for autoimmune diseases

Country Status (2)

Country Link
AU (1) AUPQ272699A0 (en)
WO (1) WO2001018541A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
NZ556065A (en) 2005-01-24 2009-04-30 Univ Texas FC-fusion constructs binding to phosphatidylserine and their therapeutic use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874409A (en) * 1995-06-07 1999-02-23 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
IL125262A0 (en) * 1998-07-07 1999-03-12 Yeda Res & Dev Synthetic peptides and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
WO2001018541A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
AU2815900A (en) Clinical and diagnostic database
AU4991100A (en) Mobile ultrasound diagnostic instrument and docking stand
AU2002227184A1 (en) Methods for development and use of diagnostic and therapeutic agents
AU9383098A (en) Novel targeted contrast agents for diagnostic and therapeutic use
AU4286699A (en) Apron for performing ecg tests and additional examinations
AU4461900A (en) Device for shaping infarcted heart tissue and method of using the device
EP1049636A4 (en) Medical procedure kit
AU3182999A (en) Methods of diagnosis and triage using cell activation measures
AUPQ886100A0 (en) Diagnostic test
AU5459000A (en) Highly sensitive biological agent probe
AU2789397A (en) Diagnostic drugs for autoimmune diseases
AU5252698A (en) Therapeutic compositions and methods and diagnostic assays for type ii diabetes involving hnf-1
AU3760400A (en) Methods and reagents for the diagnosis and treatment of multiple sclerosis
AU2191297A (en) Blood testing kit
AU4202699A (en) Human socs proteins
IL129024A0 (en) Use of proteins as agent against autoimmune diseases
AU2087799A (en) Diagnostic and therapeutic methods based upon valpha24jalphaq t cells
AU5672300A (en) Diagnostic device
AU6835300A (en) Diagnostic kit and use thereof
AU6961298A (en) Therapeutic compositions and diagnostic assays for diseases involving trbp
AUPQ272699A0 (en) Use of beta2GPI in diagnostic tests for autoimmune diseases
PL336978A1 (en) Strip-type test for performing an allergy diagnosis in vitro
AU7393000A (en) Use of beta2gpi in diagnostic tests for autoimmune diseases
AU6509698A (en) Methods for clinical diagnosis
AU7262800A (en) Diagnostic and therapeutic methods in autoimmune disease

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 7393000

Country of ref document: AU